【石药集团(01093.HK)开发的高浓度盐酸羟钴胺注射液获批开展临床试验 用于治疗罕见病甲基丙二酸血症】智通财经APP

智通财经
Jul 03, 2025
【石药集团(01093.HK)开发的高浓度盐酸羟钴胺注射液获批开展临床试验 用于治疗罕见病甲基丙二酸血症】智通财经APP讯,石药集团(01093.HK)公布,该集团开发的高浓度盐酸羟钴胺注射液已获中华人民共和国国家药品监督管理局批准,可在中国开展临床试验,用于治疗罕见病甲基丙二酸血症(MMA)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10